Jane Street’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.58M | Buy |
+748,652
| New | +$1.58M | ﹤0.01% | 2368 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 5916 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 6142 |
|
2024
Q2 | – | Sell |
-36,785
| Closed | -$87.9K | – | 6253 |
|
2024
Q1 | $87.9K | Buy |
36,785
+3,016
| +9% | +$7.21K | ﹤0.01% | 5283 |
|
2023
Q4 | $56.1K | Buy |
+33,769
| New | +$56.1K | ﹤0.01% | 5386 |
|
2023
Q2 | – | Sell |
-40,522
| Closed | -$85.1K | – | 5550 |
|
2023
Q1 | $85.1K | Buy |
40,522
+5,124
| +14% | +$10.8K | ﹤0.01% | 4998 |
|
2022
Q4 | $40K | Buy |
+35,398
| New | +$40K | ﹤0.01% | 4931 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 5837 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 5537 |
|
2021
Q3 | – | Sell |
-11,133
| Closed | -$36K | – | 5436 |
|
2021
Q2 | $36K | Buy |
+11,133
| New | +$36K | ﹤0.01% | 4996 |
|
2019
Q4 | – | Sell |
-23,849
| Closed | -$88K | – | 3486 |
|
2019
Q3 | $88K | Buy |
+23,849
| New | +$88K | ﹤0.01% | 3196 |
|
2019
Q2 | – | Sell |
-22,029
| Closed | -$113K | – | 3679 |
|
2019
Q1 | $113K | Buy |
+22,029
| New | +$113K | ﹤0.01% | 3071 |
|
2018
Q3 | – | Sell |
-14,369
| Closed | -$91K | – | 3628 |
|
2018
Q2 | $91K | Buy |
+14,369
| New | +$91K | ﹤0.01% | 3069 |
|
2014
Q3 | – | Sell |
-19,096
| Closed | -$264K | – | 2376 |
|
2014
Q2 | $264K | Buy |
19,096
+5,745
| +43% | +$79.4K | ﹤0.01% | 1684 |
|
2014
Q1 | $204K | Buy |
+13,351
| New | +$204K | ﹤0.01% | 2072 |
|
2013
Q4 | – | Sell |
-10,076
| Closed | -$100K | – | 2263 |
|
2013
Q3 | $100K | Buy |
+10,076
| New | +$100K | ﹤0.01% | 2257 |
|